Welcome to our dedicated page for Balchem news (Ticker: BCPC), a resource for investors and traders seeking the latest updates and insights on Balchem stock.
Balchem Corporation reports developments tied to its specialty ingredient manufacturing business for health, nutrition, agriculture, healthcare, and other industrial markets. The company operates through Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products, with recurring updates on segment sales, earnings, cash flow, debt, share repurchases, and conference participation.
Company news also includes product and market developments such as customized food and beverage ingredient systems, key nutrients for food, supplement, and pharmaceutical applications, animal nutrition products, choline chloride, specialty-packaged chemicals, and chelated minerals for micronutrient agriculture. Updates have included the Metalosate® T.E.A.M.™ plant tissue analysis platform and trade actions affecting choline chloride supply chains.
Balchem (NASDAQ: BCPC) reported record net sales of $239.7 million, net earnings of $29.0 million, adjusted EBITDA of $60.9 million, and free cash flow of $26.8 million for the first quarter of 2024. The Human Nutrition & Health segment saw significant growth, with sales up 15.1% and earnings up 80.4% compared to the prior year. The Animal Nutrition & Health segment experienced a decrease in sales, while the Specialty Products segment remained stable. The company's strong financial performance and sustainability initiatives signal a positive outlook for 2024.
The New York Jets have announced a multi-year partnership with VitaCholine, a Balchem Human Nutrition and Health brand, marking VitaCholine's first sponsorship and the first sponsorship in the Nutritional Ingredient category of a major professional sports team. The agreement includes territorial rights in the United States and the United Kingdom, entitlement of the New York Jets official website, and presenting partner status for a Jets road game. VitaCholine will be featured prominently on the team's website and at MetLife Stadium, aiming to raise awareness about the essential nutrient choline and its health benefits. This collaboration highlights the growing demand for solutions supporting mental and physical performance in the post-pandemic era.
Balchem (BCPC) will attend the BMO 19th Annual Global Farm to Market Conference on May 16, 2024. The conference will be attended by top executives, including Chairman Ted Harris, CFO Martin Bengtsson, and Senior Director Investor Relations Allison Baurichter.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.